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ABSTRACT
The knowledge about interactions between
proteins and small molecules is essential for the
understanding of molecular and cellular functions.
However, information on such interactions is
widely dispersed across numerous databases and
the literature. To facilitate access to this data,
STITCH (‘search tool for interactions of chemicals’)
integrates information about interactions from
metabolic pathways, crystal structures, binding
experiments and drug–target relationships. Inferred
information from phenotypic effects, text mining
and chemical structure similarity is used to predict
relations between chemicals. STITCH further
allows exploring the network of chemical relations,
also in the context of associated binding proteins.
Each proposed interaction can be traced back to
the original data sources. Our database contains
interaction information for over 68000 different
chemicals, including 2200 drugs, and connects
them to 1.5 million genes across 373 genomes and
their interactions contained in the STRING data-
base. STITCH is available at http://stitch.embl.de/
INTRODUCTION
In pharmacology and biochemistry the interplay of
chemicals and proteins has been studied over many
years, but much of the existing data on chemicals is
either hidden in a vast amount of dispersed literature or is
locked away in commercial databases such as the
Chemical Abstracts Service Registry. Recently, however,
several projects have begun to provide easy public access
to chemical information. Resources such as PubChem (1),
ChEBI (2) and ChemDB (3) provide an ever-growing
inventory of the chemical space that can be used as the
basis for the integration of knowledge about chemicals
themselves, their biological interactions and their pheno-
typic eﬀects. Thus, many problems in Chemical Biology
are now becoming approachable by the academic research
community.
Valuable information about the biological activity of
chemicals is provided by large-scale experiments.
Phenotypic eﬀects of chemicals were ﬁrst made available
on a large scale by the US National Cancer Institute (NCI),
which conducts anti-cancer drug screens on 60 human
tumour cell lines (NCI60) (4). The patterns of growth
inhibition in the diﬀerent cell lines by small molecules can
not only be used to judge the eﬃcacy of individual
compounds, but also to relate compounds by their
mechanism of action (5,6). Other unexpected relationships
between compounds can be found using the PubChem
BioAssay resource, where NCI60 data and many other
assays are aggregated. As of July 2007, it contains 587
highly diverse assays, ranging from studies of single
molecules to high-throughput screens with over 100000
tested substances. Recently, the Connectivity Map project
(7) set out to catalogue the perturbations in gene
expression upon chemical treatment. As the Connectivity
Map increases in coverage of small molecules, it will
develop into a very useful resource for both the
similarities of chemicals and the relations of chemicals
with proteins.
Information about interactions between proteins
and small molecules is essential for understanding
metabolism, signalling and drug treatment. Part of this
information is stored in diﬀerent types of databases. There
are some databases that focus on the biological actions
of drugs, for example DrugBank (8), TTD (9),
SuperTarget and MATADOR (10). Another database,
the PDSP Ki Database (11) provides protein binding
constants (Ki) for compounds, combining data from
the literature and internal screens. Finally, there are
many pathway databases most prominently KEGG (12),
MetaCyc (13) and Reactome (14). These diverse
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between chemical space and the protein universe through
genome databases such as Ensembl (15) and RefSeq (16).
In order to get a complete picture of the biochemistry of
metabolites, drugs and other compounds, the current
challenge is to integrate the various sources of chemical
knowledge into a single resource and to link it with the
knowledge about proteins. For example, to be able to link
phenotypic observations from cell line screens to mole-
cular events, their interactions with proteins in the context
of cellular networks are essential.
Here, we present search tool for interactions of chemical
(STITCH), a search tool and resource for the interactions
of chemicals and proteins. A consolidated set of chemicals
is derived from PubChem. Relations between chemicals
are derived from similar activity proﬁles in the NCI60
cell lines, from pharmacological actions assigned to
chemicals in the Medical Subject Headings (MeSH) and
from the literature. Chemical–chemical and chemical–
protein associations are integrated from pathway and
experimental databases, as well as from the literature.
Lastly, as many associations as possible are annotated
with interaction types.
CONSOLIDATED SET OF CHEMICALS
Chemicals are the basis of STITCH and are currently
imported from PubChem. All stereoisomers and charge
forms of a compound are merged into one record via
the canonical SMILES string. While this might be an over-
simpliﬁcation, it is necessary and valid for three reasons:
Stereoisomers often share names, for example the name
‘valine’ is assigned to L-valine, D-valine and a third
compound without stereochemistry and therefore, it is
not possible to automatically assign the synonym. Second,
external databases may link to the compound with or
without stereochemistry. Lastly, enantiomers with diﬀ-
erent biological activity may interconvert in vivo. This is
the case for the drug thalidomide, where one enantiomer
can be used to treat morning sickness, but the other
enantiomer causes birth defects (17).
Drugs are often marketed as diﬀerent salts and mixtures
of the same active substance, which are represented as
distinct entries in the chemical databases. As the diﬀerent
formulations will have the same biological eﬀect, they are
joined into one entry in STITCH. In order to do this, a list
of 30 additive compounds that can be discarded was
created by manual inspection of mixtures. This list
includes water, ions such as calcium and organic acids
such as methanesulfonic acid (which forms mesylates).
When these compounds are present together with
an organic compound of at least 100g/mol, the additive
compounds are discarded and the database entry of the
mixture is joined to the entry of the base compound.
For example, imatinib mesylate is reduced to its main
form imatinib.
The PubChem database is an aggregation of many
databases. Often, diﬀerent databases contradict each other
in the assignment of synonyms to compounds. For this
reason, some of the source databases have been identiﬁed
as either trusted or dubious sources. This information is
used to arbitrate conﬂicts in the assignment of synonyms.
ASSOCIATIONS BETWEEN CHEMICALS
Building upon the set of chemicals, associations of
chemicals and proteins can be imported from various
sources. Taken together, these associations form a
network that can be used to explore the context of
chemicals and proteins. The associations derived here
are combined with protein–protein interactions stored in
the STRING database (18) to form one large network.
Four types of edges link chemicals in the chemical–
chemical network: reactions from pathway databases,
literature associations, similar structures and similar
activities. Pathway databases contain records about
chemical reactions that are used to derive associations.
The open-source Chemistry Development Kit (19) was
used to calculate chemical ﬁngerprints and the commonly
used Tanimoto 2D chemical similarity scores (20,21).
Literature associations were derived in the same manner
as chemical–protein associations (see subsequently).
To predict whether two chemicals have similar mole-
cular activities, data from MeSH pharmacological
actions and activities in the NCI60 screens were used.
Compounds from MeSH were mapped by their name to
the database of chemicals. To assess the relevance of the
association by a shared pharmacological action, the
number of chemicals annotated with each pharmacologi-
cal action is determined and benchmarked against the
probability of sharing a drug target in the MATADOR
database.
An activity pattern was calculated for each compound
based on the NCI60 screens, by converting its log(GI50)
values (the concentrations required to inhibit growth
by 50%) to Z-scores in each cell line (6). Compounds with
uninformative activity patterns were excluded using
a threshold for the standard deviation of the Z-scores.
Then, the Pearson correlation of the activity patterns was
calculated for all compound pairs and benchmarked
against known mechanisms of action (6,22). This allows
the user to link compounds with unknown mechanism of
action to well-studied compounds (Figure 1).
SOURCES OF CHEMICAL–PROTEIN
INTERACTIONS
In order to link the derived chemical–chemical associa-
tions to the protein world, a variety of databases of
chemical–protein interactions are imported. Experimental
evidence of direct chemical–protein binding is derived
from the PDSP Ki Database (11) and the protein data
bank (PDB) (23). Additional interactions between meta-
bolites and proteins are extracted from the manually
annotated pathway databases such as KEGG (12),
Reactome (14) and the NCI-Nature Pathway Interaction
Database (http://pid.nci.nih.gov), and drug–target
relations are imported from DrugBank (8) and
MATADOR (10).
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additional evidence, based both on a simple co-occurrence
scheme and a more complex natural language processing
(NLP) approach (24,25). In order to increase the coverage
of the text-mining approach, groups of proteins that are
described in MeSH terms are also used as entities during
text mining. This allows us to capture interactions such
as the binding of memantine to multimeric NMDA
(N-methyl D-aspartate) receptors. The MeSH terms are
mapped to proteins by the identiﬁers and synonyms
provided by MeSH. If this automatic mapping is not
possible, common proteins were manually assigned to
candidate MeSH terms that were determined by using
the annotations of abstracts with MeSH terms in
MEDLINE. To reﬂect the decreased conﬁdence asso-
ciated with an interaction of a compound with a group of
proteins rather than a single protein, the interaction score
was scaled down as a function of the sequence diversity
within the group.
For each individual evidence type, likelihood or
relevance scores have been developed. The individual
scores for a given chemical–protein or chemical–
chemical interaction are then combined into one overall
score (26). Chemical–protein interactions are transferred
between species based on the sequence similarity of the
proteins (26).
In order to be as comprehensive as possible, STITCH
derives data from a variety of sources. While the sources
have diﬀerent focuses, it is well possible that certain
areas of knowledge are not covered. In the future, more
data sources will be added to further increase the coverage
of STITCH.
ANNOTATION OF SMALL MOLECULE ACTIONS
Many data sources contain information about the
biological or biochemical action associated with a certain
interaction. This information can be stated explicitly,
Figure 1. Interactions of the topoisomerase II inhibitor amsacrine. Chemicals are represented as pill-shaped nodes, while proteins are shown
as spheres. Nodes that are associated to each other are linked by an edge: like mitoxantrone, amsacrine is known to bind (blue lines) and inhibit
(red arrows) type II topoisomerases. Other compounds have similar activities as amsacrine or mitoxantrone in the NCI60 anti-cancer drug screens
and are thus predicted to have the same mechanism of action (cyan lines).
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implicitly, like in crystal structures. As one of the display
modes, STITCH allows the user to view a network of
interactions augmented by the types of actions (Figure 2).
Possible actions are: activation, inhibition, direct binding,
catalysis, (bio)chemical reaction and similar activity.
To avoid overloading the visual network representation
with a great number of edge types, this representation is
intentionally not as detailed as provided by the BioPAX
ontology or recently suggested by Lu et al. (28).
Taken together, STITCH links molecular, cellular and
phenotypic data related to small molecules and allows
easy navigation in and visualization of networks of large
collections of associations between chemicals as well as
interactions between chemicals and proteins. It thus
represents a useful resource for both in-depth and large-
scale projects in Chemical Biology.
DATABASE ACCESS AND NETWORK VIEWS
Users can query the STITCH database (http://stitch.
embl.de) in several ways. A full-text search is available for
identiﬁers and common names of chemicals and proteins.
Chemical structures may be entered as SMILES strings
to search for similar chemicals that are stored in the
database. Finally, protein sequences can be submitted to
ﬁnd similar proteins in the database.
When searching STITCH with a chemical as entry
point, the user is presented with a network of related
proteins that places the chemical into a biological context.
The network can be extended to also show related
chemicals, which is useful for highlighting, for example,
compounds with similar pharmacological activity or
metabolized forms. Querying STITCH for a protein will
provide the user with a network that places the protein
into its chemical and biological context. The network
viewer displays chemical and protein structures and
provides the user with easy access to information
from resources such PubChem (1), PDB (23) and
SMART (29).
To aid the user in exploring and interpreting the
networks, we provide four diﬀerent views. By default,
the conﬁdence view is shown (Figures 1 and 2a). There the
thickness of the lines represents the conﬁdence score of
the association. In the evidence view, separate lines with
diﬀerent colours are used to show the type of evidence
that support each interaction, for example experimental
evidence or text mining. Where possible, the actions view
uses diﬀerent colours to visualize the types of interaction
between chemicals and proteins, for example activation,
inhibition or metabolization (Figure 2b). Finally, an
interactive view allows the user to modify the network
layout.
For large-scale analyses, the interaction network of
chemicals and proteins can be downloaded from the
STITCH website. We also make available synonyms
lists for chemicals and proteins as well as a set of database
cross-references to other chemical databases. These ﬁles
are available under a Creative Commons Attribution
3.0 License.
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Figure 2. Network around acetylcholine and acetylcholinesterase
(ACHE). (a) In conﬁdence view, thicker lines represent stronger
associations. (b) Lines and, for directed edges, arrows of diﬀerent
colours stand for diﬀerent edge types in the actions view: binding
(blue), activation (green), inhibition (red), catalysis (magenta), same
activity (cyan) and reaction (black). The network shows the hydrolysis
from acetylcholine to choline that is catalysed by ACHE. Several drugs,
for example, the nootropic drug donepezil, inhibit ACHE.
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